SCHEMBL30200834

SCHEMBL30200834

COCCc1nc2c(N)nc3ccccc3c2n1CCOCCN(C)C(=O)C1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 20/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL893544 1.00 TLR7 (0.53) TLR7
SCHEMBL6031026 0.85 TLR7 (0.57) TLR7
SCHEMBL4792794 0.84 TLR7 (0.37) TLR7
SCHEMBL4336407 0.83 TLR7 (0.55) TLR7
SCHEMBL4331154 0.83 TLR7 (0.56) TLR7
SCHEMBL676401 0.82 TLR7 (0.60) TLR7
SCHEMBL29852303 0.82 TLR7 (0.60) TLR7
SCHEMBL31006041 0.82 TLR8 (0.55) TLR7
SCHEMBL17783025 0.81 TLR7 (0.51) TLR7
SCHEMBL5736958 0.81 TLR7 (0.56) TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023097237-A2 CYTOSOLIC BACTERIAL PATHOGENS ATTENUATED FOR SPREAD FROM TUMORS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-01 WO claimed
US-20250195639-A1 MULTI-EPITOPE MRNA SARS-COV-2 VACCINE FOR BOOSTING IMMUNITY THROUGH THE ACTIVATION OF CD4 AND CD8 T CELLS AS WELL AS B LYMPHOCYTES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-06-19 US disclosed
CN-110234401-B Methods and compositions for adaptive immunomodulation 德克萨斯大学系统董事会 2024-03-01 CN disclosed
US-20240033348-A1 METHODS AND COMPOSITIONS FOR ADAPTIVE IMMUNE MODULATION Pulmotect, Inc. 2024-02-01 US disclosed
US-11826422-B2 Methods and compositions for adaptive immune modulation BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-11-28 US disclosed
WO-2023097237-A2 CYTOSOLIC BACTERIAL PATHOGENS ATTENUATED FOR SPREAD FROM TUMORS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-01 WO disclosed
WO-2023069551-A1 MULTI-EPITOPE MRNA SARS-COV-2 VACCINE FOR BOOSTING IMMUNITY THROUGH THE ACTIVATION OF CD4 AND CD8 T CELLS AS WELL AS B LYMPHOCYTES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-04-27 WO disclosed
WO-2023044016-A2 ANTIBODY IMMUNE-STIMULANT CONJUGATES AND USE THEREOF CSPC DOPHEN CORPORATION (US) 2023-03-23 WO disclosed